Doxifluridine as Palliative Treatment in Advanced Gastric and Pancreatic Cancer Patients
Maria Di Bartolomeo(Fondazione IRCCS Istituto Nazionale dei Tumori), Roberto Buzzoni(Fondazione IRCCS Istituto Nazionale dei Tumori), Carlo Carnaghi(Fondazione Humanitas per la Ricerca), Corrado Gallo Stampino, Michele Del Vecchio(Fondazione IRCCS Istituto Nazionale dei Tumori), Emilio Bajetta(Fondazione Lanza), L. Somma(Luigi Sacco Hospital), Elena Bandieri(Roche (Switzerland))
Cited by 16
Related Papers
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
|New England Journal of Medicine|2017|2.2k
A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer
|New England Journal of Medicine|2004|1.8k
Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial
|The Lancet|2009|1.4k